Chronic Obstructive Pulmonary Disease

Slide 1 · Chronic Obstructive Pulmonary Disease

Airway, alveolar, and small-airway pathology

Mechanisms • morphology • clinicopathologic correlation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Distinguish airflow obstruction from a restrictive ventilatory defect.

Explain the structural patterns and mechanisms of emphysema.

Relate mucus hypersecretion and bronchiolar remodeling to chronic bronchitis.

Interpret the major morphologic findings and clinical complications of COPD.

Slide 3 · COPD: Persistent symptoms and airflow limitation

A common, preventable and treatable respiratory disease.

Characterized by persistent respiratory symptoms and airflow limitation.

Airway and/or alveolar abnormalities arise after exposure to noxious particles or gases.

A single patient may exhibit multiple overlapping pathologic components.

Slide 4 · Obstructive and restrictive physiology are distinct

Characteristic

Obstructive pattern

Restrictive pattern

Primary defect

Increased resistance to expiratory airflow

Reduced lung expansion and total lung capacity

Forced expiration

Maximal expiratory flow is reduced

FEV₁ and FVC tend to decline proportionately

FEV₁/FVC

Typically decreased

Often preserved

Slide 5 · Spirometry detects the obstructive defect

Typical spirometric finding in COPD

FEV₁ / FVC < 0.7

FEV₁: Forced expiratory volume in 1 second.

FVC: Forced vital capacity.

Airflow limitation is established by spirometry, not by cough alone.

Slide 6 · COPD reflects disease at several anatomic levels

Bronchi

Mucus gland enlargement and excess secretions

Bronchioles

Inflammation, mucus plugging and fibrotic narrowing

Acini

Alveolar-wall destruction and reduced recoil

Three anatomic sites — schematic

Slide 7 · The two major components commonly coexist

Emphysema

Enlargement of distal airspaces

Destruction of alveolar walls

Reduced parenchymal elastic recoil

Chronic bronchitis

Persistent productive cough

Mucus hypersecretion and inflammation

Airway narrowing / bronchiolar fibrosis

Slide 8 · Small-airway disease contributes independently

Bronchiolitis affects bronchioles rather than the large conducting airways.

Chronic inflammation and fibrosis constrict narrow-caliber lumina.

It adds airflow resistance even when emphysematous tissue destruction dominates.

Obstructive pathology is therefore more than mucus in large bronchi.

Slide 9 · Cigarette smoke is the principal shared exposure

Inhaled smoke

Repeated epithelial injury and impaired clearance

Inflammatory response

Leukocyte recruitment; Oxidant and protease activity

Chronic damage

Parenchymal destruction plus airway remodeling

Causal sequence — schematic

Slide 10 · Susceptibility extends beyond smoking

Poor early-life lung development may limit attained respiratory reserve.

Environmental and occupational pollutants add chronic inhalational exposure.

Airway hyperresponsiveness contributes in susceptible individuals.

Genetic variation affects risk, including antiprotease pathways.

Slide 11 · Shared exposure does not produce identical pathology

Predominant alveolar injury

Loss of interalveolar septa

Reduced elastic recoil

Expiratory airway collapse

Predominant airway injury

Gland and goblet-cell responses

Inflammatory thickening

Mucus plugging and fixed narrowing

Slide 12 · Why emphysema and bronchitis are taught separately

They frequently occur together in the same person with COPD.

Their central structural lesions differ: Alveolar wall versus airway wall.

Each has a distinct mechanism of airflow limitation.

Understanding both mechanisms explains heterogeneous clinical presentations.

Slide 13 · Emphysema: A structural definition

Irreversible enlargement of airspaces distal to terminal bronchioles.

Accompanied by destruction of alveolar walls.

The definition is morphologic: Dilatation alone is insufficient.

Anatomic location within the acinus determines the emphysema pattern.

Slide 14 · The respiratory acinus is the unit of injury

Acinar distribution — schematic (not histology)

Characteristic distribution

Terminal bronchiole leads to respiratory bronchioles.

Alveolar ducts and alveoli form distal gas-exchanging units.

The pulmonary lobule contains clusters of acini.

Slide 15 · Centriacinar emphysema begins proximally

Acinar distribution — schematic (not histology)

Characteristic distribution

Respiratory bronchioles within the acinus dilate and lose walls.

Relatively spared distal alveoli may coexist in the same acinus.

Severe disease may eventually extend into distal airspaces.

Slide 16 · Centriacinar emphysema predominates in smokers

The most common emphysematous pattern in clinically significant COPD.

Strongly associated with heavy cigarette smoking.

Lesions are usually more marked in upper lobes and apical segments.

Central damage may become confluent with advanced disease.

Slide 17 · Panacinar emphysema involves the entire acinus

Acinar distribution — schematic (not histology)

Characteristic distribution

Enlargement extends from respiratory bronchiole to terminal alveoli.

Relatively uniform acinar involvement contrasts with centriacinar sparing.

Typically more severe in lower lung zones and bases.

Slide 18 · Panacinar emphysema points toward antiprotease deficiency

Classically associated with α₁-antitrypsin deficiency.

Smoking amplifies risk and accelerates structural injury.

The acinus is involved more uniformly than in smoking-related centriacinar disease.

The distribution is often basilar rather than apical.

Slide 19 · Centriacinar versus panacinar emphysema

Feature

Centriacinar

Panacinar

Acinar region

Proximal / respiratory bronchiolar

Entire acinus

Usual association

Cigarette smoking

α₁-antitrypsin deficiency

Lung predominance

Upper lobes / apices

Lower zones / bases

Distal alveoli initially

Relatively preserved

Involved

Slide 20 · Paraseptal emphysema preferentially affects distal acini

Acinar distribution — schematic (not histology)

Pleural edge

Characteristic distribution

Proximal acinus is relatively preserved.

Distal airspaces near pleura or lobular septa are enlarged.

Subpleural blebs can predispose to spontaneous pneumothorax.

Slide 21 · Paraseptal emphysema has a characteristic location

Pronounced adjacent to pleura and interlobular connective tissue septa.

May occur near fibrosis, scar, or atelectatic lung.

Often more conspicuous in the upper half of the lung.

Can create cyst-like enlarged airspaces and subpleural blebs.

Slide 22 · Irregular emphysema accompanies scars

The acinus is affected unevenly rather than in a reproducible uniform pattern.

Almost invariably accompanies areas of pulmonary scarring.

Often limited to small foci.

Usually of less clinical importance than centriacinar and panacinar disease.

Slide 23 · Pattern recognition begins with acinar localization

Pattern

Principal site

Typical association

Centriacinar

Proximal acinus

Smoking; upper-lobe disease

Panacinar

Whole acinus

α₁-antitrypsin deficiency; bases

Paraseptal

Distal subpleural acinus

Subpleural blebs / pneumothorax

Irregular

Scattered, scar-adjacent

Pulmonary fibrosis and scars

Slide 24 · Emphysema begins with toxic epithelial injury

Smoke / noxious inhalants

Injury to respiratory epithelial cells

Local signals

Proinflammatory mediators and chemotaxis

Chronic response

Leukocyte accumulation and matrix injury

Causal sequence — schematic

Slide 25 · Inflammatory mediators amplify alveolar damage

Injured epithelium and resident macrophages release inflammatory mediators.

Leukotriene B₄ and IL-8 are among mediators associated with recruitment.

TNF and other cytokines amplify inflammatory reactions.

Growth-factor signals contribute to tissue remodeling.

Slide 26 · Innate inflammatory cells drive proteolytic injury

Cytokine / chemotactic signaling

Neutrophils and other inflammatory cells enter lung

Enzymatic release

Proteases digest extracellular connective tissue

Structural loss

Elastin-containing septa and acinar architecture are damaged

Causal sequence — schematic

Slide 27 · Adaptive lymphocytes accumulate, but their role is uncertain

T and B lymphocytes are found in chronically inflamed lung regions.

Their accumulation accompanies sustained smoking-associated injury.

The specific contribution of adaptive immunity to emphysema remains uncertain.

Morphologic association does not by itself establish causal primacy.

Slide 28 · Protease–antiprotease balance protects alveolar walls

Inflammatory activation

Neutrophils release elastase and other proteases

Insufficient restraint

Deficient α₁-antitrypsin permits proteolysis

Net tissue injury

Unopposed extracellular matrix degradation

Causal sequence — schematic

Slide 29 · α₁-Antitrypsin inhibits neutrophil elastase

An antiprotease present in serum, tissue fluids, and macrophages.

Restrains proteases released by activated neutrophils.

Deficiency weakens protection against destruction of elastic tissue.

Provides a mechanistic link between inherited susceptibility and emphysema.

Slide 30 · The Pi locus provides the genetic context

The proteinase inhibitor (Pi) locus is located on chromosome 14.

The locus is polymorphic; The Z allele is linked to deficient circulating α₁-antitrypsin.

Severe deficiency predisposes to an earlier, often basilar panacinar pattern.

Genetic susceptibility interacts strongly with smoking exposure.

Slide 31 · Smoking and α₁-antitrypsin deficiency act together

Inherited antiprotease deficiency

Reduced elastase inhibition

Tobacco-induced inflammation

Increased neutrophil influx and protease release

Combined effect

Accelerated loss of elastic lung connective tissue

Convergent mechanisms — schematic

Slide 32 · Oxidative stress adds a second major injury mechanism

Oxidants are generated by tobacco smoke, inflammatory cells, and tissue injury.

Excess oxidant exposure causes direct tissue injury and promotes inflammation.

Endothelial dysfunction may accompany oxidant-mediated damage.

Oxidative stress acts alongside protease imbalance rather than replacing it.

Slide 33 · NRF2 coordinates cellular antioxidant defenses

Intracellular oxidants

Activation of the oxidant-response sensor NRF2

Transcriptional response

Expression of cytoprotective antioxidant genes

Protective effect

Reduced susceptibility to oxidant-mediated cellular injury

Causal sequence — schematic

Slide 34 · Why NFE2L2 matters in emphysema

NFE2L2 encodes the transcription factor NRF2.

Experimental inactivation makes mice more vulnerable to tobacco smoke injury.

Human variants in the NRF2 response pathway are associated with smoking-related lung disease.

The experimental and genetic observations support an oxidant-stress mechanism.

Slide 35 · Infection typically exacerbates pre-existing emphysema

Bacterial and viral infections are not considered primary initiators of emphysematous destruction.

Superimposed infection can trigger marked clinical deterioration.

Exacerbations occur against a background of damaged parenchyma and compromised airways.

Distinguish cause of chronic injury from trigger of an acute episode.

Slide 36 · The mechanisms converge on irreversible wall loss

Toxic injury

Inflammatory recruitment and oxidant production

Unopposed proteolysis

Elastin and other matrix components degraded

Alveolar-wall destruction

Enlarged airspaces, capillary loss, impaired recoil

Causal sequence — schematic

Slide 37 · Elastic recoil normally holds small airways open

Small-airway cross-section — schematic

Why airflow changes

Alveolar septa apply radial traction to nearby bronchioles.

Intact elastic tissue helps prevent expiratory narrowing.

Patent small airways support expiratory airflow.

Slide 38 · Lost radial traction promotes expiratory collapse

Small-airway cross-section — schematic

Why airflow changes

Emphysema destroys elastic septa and airway attachments.

Reduced outward traction permits bronchiolar collapse on expiration.

Obstruction may be functional without a solid luminal blockage.

Slide 39 · Two processes narrow airflow in emphysema

Loss of elastic support

Reduced radial traction

Early airway collapse during exhalation

Reduced elastic recoil

Small-airway inflammation

Bronchiolar wall thickening

Peribronchiolar fibrosis

Additional narrowing of the airway lumen

Slide 40 · Gross emphysema produces voluminous lungs

Lungs become overinflated and may overlap the heart anteriorly.

The diaphragm is flattened by persistent hyperinflation.

Smoking-associated damage is usually greater in upper lung regions.

Large enlarged airspaces may be evident on lung cut surfaces.

Slide 41 · The microscopic signature is alveolar-wall destruction

Enlarged airspaces are separated by attenuated septa.

Focal centriacinar fibrosis may be present.

Destroyed septa can terminate as blind, club-shaped remnants.

Airspace enlargement reflects actual loss of tissue architecture.

Slide 42 · Capillary loss follows septal destruction

Loss of interalveolar septa

Fewer alveolar capillary-bearing walls

Reduced vascular bed

Less available gas-exchange interface

Functional consequence

Impaired diffusion; Pulmonary vascular effects

Causal sequence — schematic

Slide 43 · Advanced emphysema can create blebs and bullae

Confluent wall destruction creates abnormally large airspaces.

Blebs and bullae may distort adjacent bronchioles and pulmonary vessels.

Subpleural blebs are clinically relevant because rupture can cause pneumothorax.

These are consequences of structural injury, not a substitute for microscopic diagnosis.

Slide 44 · Chronic bronchitis is defined by cough and sputum

Clinical definition of chronic bronchitis

≥ 3 months / year × ≥ 2 years

Persistent productive cough meets this duration pattern.

The two years are consecutive.

No other identifiable cause should account for the chronic productive cough.

Slide 45 · Bronchitis begins with chronic inhalational irritation

Tobacco smoke / inhaled dust

Damage to respiratory epithelial lining

Defensive epithelial response

Increased mucus production and inflammatory signaling

Persistent irritation

Mucus hypersecretion plus chronic airway remodeling

Causal sequence — schematic

Slide 46 · Large-airway mucous glands enlarge early

Mucus hypersecretion initially becomes prominent in large airways.

Enlarged submucosal glands are a characteristic tissue response.

Accumulated secretions contribute to persistent productive cough.

Gland enlargement is distinct from the bronchiolar fibrosis that fixes obstruction.

Slide 47 · Goblet-cell expansion extends mucus production distally

Goblet-cell numbers increase in smaller bronchi and bronchioles.

Excess mucus can plug narrow bronchiolar lumina.

Distal plugging adds a direct mechanical component to airflow obstruction.

A response that may be protective becomes harmful when prolonged.

Slide 48 · Histamine and IL-13 participate in mucus hypersecretion

Inflammatory mediators contribute to enlargement and secretory responses.

Histamine and interleukin-13 are implicated by the textbook.

The full basis of mucus hypersecretion remains incompletely understood.

Do not mistake mediator association for a complete single-pathway explanation.

Slide 49 · Smoking can cause acquired CFTR dysfunction

Cigarette-smoke exposure

Acquired dysfunction of CFTR

Airway surface secretions

Mucus becomes abnormally dehydrated

Airway outcome

Thicker secretions worsen clearance and obstruction

Causal sequence — schematic

Slide 50 · Inflammation creates a self-sustaining airway injury

Damaging inhalants induce acute and chronic inflammatory responses.

Neutrophils, macrophages, and lymphocytes participate.

Persistent inflammatory injury drives wall thickening and fibrosis.

Exacerbation and baseline structural disease involve related but distinct processes.

Slide 51 · Smoke compromises the mucociliary escalator

Ciliary dysfunction

Impaired propulsion of bronchial mucus

Retention of secretions

Microorganisms are cleared less effectively

Clinical consequence

Greater susceptibility to infection and exacerbations

Causal sequence — schematic

Slide 52 · Infection perpetuates bronchitis but rarely initiates it

The initiating exposure is usually chronic inhalational irritation.

Infection can help maintain airway inflammation once established.

Acute infectious episodes are important triggers of exacerbations.

Separate the longitudinal pathogenesis from episodic clinical worsening.

Slide 53 · Small-airway fibrosis generates fixed resistance

Chronic bronchiolar inflammation

Long-standing tissue injury

Repair and remodeling

Smooth-muscle change plus extracellular matrix deposition

Luminal narrowing

Fibrosis may severely compromise or obliterate small airways

Causal sequence — schematic

Slide 54 · Gross bronchitis features congested, mucus-filled airways

Airway mucosa can be hyperemic, swollen, and edematous.

Mucinous or mucopurulent secretions are often excessive.

Thick casts may fill bronchi and bronchioles.

Gross appearances reflect mucosal inflammation and secretory excess.

Slide 55 · Microscopy shows chronic bronchial wall remodeling

Chronic inflammatory infiltrates are rich in lymphocytes and macrophages.

Bronchiolar smooth muscle may be hypertrophied.

Extracellular matrix deposition and peribronchiolar fibrosis thicken walls.

Goblet cells and mucus-secreting glands are increased.

Slide 56 · Reid index quantifies the mucous gland layer

Lumen

Epithelium

Non-glandular tissue

Mucous glands

Additional connective tissue

Cartilage

Gland thickness

Reid index = gland-layer thickness / wall thickness

Measured between bronchial epithelium and cartilage.

A value around 0.4 is described as normal in the source.

In chronic bronchitis the index tends to rise with severity and duration.

Slide 57 · Mucus and fibrosis can close bronchiolar lumina

Small-airway cross-section — schematic

Mucus

Why airflow changes

Intraluminal mucus physically reduces available airway caliber.

Peribronchial inflammation and fibrosis thicken the wall.

Advanced remodeling can culminate in luminal obliteration.

Slide 58 · Tobacco injury may produce epithelial atypia

Bronchial epithelium may undergo squamous metaplasia.

Dysplasia can accompany chronic exposure to mutagenic smoke constituents.

Metaplasia and dysplasia are distinct from mucous gland hyperplasia.

These epithelial changes reflect chronic irritation and mutagenic injury.

Slide 59 · Emphysema and bronchitis obstruct by different routes

Mechanism

Emphysema

Chronic bronchitis

Principal structure

Alveolar septa / small-airway supports

Bronchi and bronchioles

Dominant change

Tissue destruction and recoil loss

Mucus, inflammation, fibrosis

Major flow effect

Dynamic expiratory collapse

Luminal narrowing and plugging

Diagnostic focus

Acinar destruction

Secretory and airway-wall changes

Slide 60 · COPD usually begins insidiously

Exercise-related dyspnea develops slowly and increases over time.

Chronic cough may be mild initially but becomes more prominent.

Sputum production varies with the bronchitic component.

Infectious exacerbations may be the first striking clinical presentation.

Slide 61 · Symptoms fluctuate within persistent structural disease

COPD symptoms may wax and wane despite lasting structural abnormalities.

Symptoms can be more pronounced in the morning.

Superimposed infections can produce marked episodic deterioration.

A wheeze during exacerbation does not by itself establish asthma.

Slide 62 · Emphysema-dominant COPD has recognizable physiology

Characteristic findings

Prominent exertional dyspnea

Barrel-shaped, hyperinflated chest

Prolonged expiration; Pursed-lip breathing

Functional correlations

Marked overdistension of the lungs

Reduced pulmonary diffusion capacity

Resting blood gases may remain relatively preserved

Slide 63 · Bronchitis-dominant COPD emphasizes secretions

Common presentation

Persistent sputum-producing cough

Frequent infective exacerbations

Airway resistance increased

Advanced gas-exchange consequences

Hypoxemia and hypercapnia

Cyanosis in severe cases

Pulmonary hypertension and cor pulmonale

Slide 64 · The classic COPD phenotypes are extremes, not categories

Historical descriptions contrast emphysema-dominant and bronchitis-dominant patients.

Most patients have mixed emphysematous and bronchitic changes.

The relative components influence symptoms, gas exchange, and imaging.

Avoid treating classical labels as mutually exclusive modern diagnoses.

Slide 65 · Airflow obstruction is not specific to COPD

Disease

Leading lesion

Helpful clinical distinction

COPD

Chronic bronchiolar and/or acinar damage

Persistent limitation; exposure-related

Asthma

Bronchospasm, inflammatory response

Often reversible/episodic component

Bronchiectasis

Permanent bronchial dilation and scarring

Chronic purulent sputum; infection

Slide 66 · Asthma and COPD can have overlapping reversibility

Asthma is classically distinguished by reversible bronchospasm.

Some patients with asthma develop a persistent, less reversible component.

Some patients with typical COPD show a partially reversible component.

Interpret airflow physiology alongside exposure history and structural disease.

Slide 67 · Hypoxemia and vascular-bed loss promote pulmonary hypertension

Chronic parenchymal / airway disease

Regional hypoxemia and lost alveolar capillaries

Pulmonary vascular effects

Increased pulmonary vascular load

Cardiac consequence

Pulmonary hypertension and cor pulmonale

Causal sequence — schematic

Slide 68 · Acute infection can precipitate respiratory failure

Chronic COPD

Limited respiratory reserve

Superimposed infection

Worsened airflow obstruction and gas exchange

Severe exacerbation

Acute respiratory failure and potentially death

Causal sequence — schematic

Slide 69 · Rupture of a subpleural bleb causes pneumothorax

Subpleural emphysematous bleb

Weakened, enlarged peripheral airspace

Rupture

Air passes into the pleural cavity

Complication

Pneumothorax may become life-threatening

Causal sequence — schematic

Slide 70 · Mucus plugs have clinical as well as mechanical significance

Mucus plugs may block bronchiolar lumina and worsen airflow limitation.

Retention of secretions contributes to infection susceptibility.

The source notes an association between mucus plugging and all-cause mortality.

An association does not establish that a mucus plug independently causes death.

Slide 71 · Intervention targets exposure, airflow and complications

Smoking cessation and prevention of inhalational exposure address upstream injury.

Bronchodilators, selected inhaled anti-inflammatory treatment, and oxygen therapy.

Exacerbations may require antimicrobial and supportive treatment.

Selected patients may undergo bullectomy, lung-volume reduction, or transplantation.

Slide 72 · Prevention is central because structural destruction persists

Emphysematous alveolar-wall loss is anatomically irreversible.

Fixed bronchiolar fibrosis is not equivalent to transient bronchospasm.

Avoiding smoke and other harmful particles may limit ongoing injury.

Early intervention is therefore mechanistically important.

Slide 73 · Case: Progressive dyspnea and apical injury

Clinical scenario

A long-standing smoker reports increasing exercise intolerance. Imaging describes hyperinflation. A lung specimen shows predominant injury around respiratory bronchioles in upper-lobe acini.

Question

Which emphysema pattern best matches the localization, and what accounts for expiratory limitation?

Interpretation

Centriacinar emphysema. Septal elastin loss reduces radial traction, allowing small-airway collapse during expiration.

Slide 74 · Case: Diffuse basilar acinar enlargement

Clinical scenario

A younger patient develops severe emphysema with lower-zone predominance. Histology shows diffuse enlargement from respiratory bronchioles through distal alveoli.

Question

Which etiologic susceptibility is especially important, and why?

Interpretation

α₁-Antitrypsin deficiency. Reduced elastase inhibition permits excessive proteolysis; Smoking further increases risk.

Slide 75 · Case: Productive cough and thickened bronchi

Clinical scenario

A patient has productive cough for four months each year over three consecutive years. Large airways show enlarged submucosal glands; Bronchioles contain plugs and peribronchiolar fibrosis.

Question

Does the clinical definition of chronic bronchitis apply, and which lesion causes fixed obstruction?

Interpretation

Yes, after excluding another cause. Fibrotic remodeling of small bronchioles causes a fixed component, supplemented by mucus plugging.

Slide 76 · Case: Sudden deterioration in advanced COPD

Clinical scenario

A person with advanced emphysema develops acute pleuritic symptoms and abrupt breathlessness. Known peripheral airspaces include large subpleural blebs.

Question

What mechanical complication should be considered?

Interpretation

Rupture of a subpleural bleb can produce pneumothorax.

Slide 77 · Integrated pathology: Where each symptom originates

Finding

Dominant structural/pathophysiologic basis

Progressive dyspnea

Air trapping, expiratory collapse, reduced gas exchange

Chronic sputum

Large-airway gland hypertrophy and goblet-cell hyperplasia

Low diffusion capacity

Alveolar septal and capillary-bed loss

Cor pulmonale

Pulmonary hypertension with chronic gas-exchange disease

Slide 78 · Final synthesis: COPD is two injuries plus small-airway disease

Alveoli

Emphysema destroys septa, capillaries and elastic support.

Bronchi

Chronic bronchitis increases mucus secretion and produces cough.

Bronchioles

Inflammation, mucus and fibrosis narrow distal airways.

Patient

These lesions combine to cause persistent airflow limitation and complications.

Slide 79 · Primary reference and source boundaries

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. Chapter 15, “The Lung,” printed pp. 617–622.

Teaching text is based on the supplied Robbins Markdown conversion and the archived COPD and obstructive-lung-disease topic extracts.

Diagrams are original editable educational schematics; no textbook photographs or clinical specimens are reproduced.

The original chapter PDF was not supplied for figure-by-figure verification.